Aesthetics

There are plenty of laser technologies for the practice, but then there are cornerstone lasers every practice should have. Learn more in this article from the Fall Clinical conference.

Increasingly higher doses of incobotulinumtoxinA (Xeomin) offer patients a longer duration of response in the treatment for glabellar frown lines, according to recently-presented clinical trial results.

A single treatment for cellulite, which affects 85 percent of women, can reduce the appearance of fat on patients’ buttocks and thighs for five years, according to results of a multi-year effectiveness study.

A minimally-invasive surgical skin contouring procedure, currently under investigation, could give patients a new option for removing fat and tightening skin, according to recent clinical trial findings.

At the recently concluded American Society for Dermatologic Surgery meeting in Phoenix, Arizona, researchers looked at the efficacy of using picosecond lasers to  treat melasma, with the aim of reducing adverse effects from current treatment options. The treatment proves to be promising.

Researchers presenting at ASDS show that CR-PCSS and the PR-PCSS scales are reliable tools used to evaluate cellulite severity.

Cosmetic injections have increased in men, but men don’t often achieve the same results as women. To provide the same degree of success, dermatologists should take into consideration the more masculine features, according to several studies published recently.

Dermatologists can use online patient reviews as a tool to educate patients about minimally-invasive fat reduction procedures, according to a new study.

In this month's Cosmetic Conundrums column, Dr. Draelos addresses cosmeceutical peptides and the differences between carrier peptides, signal peptides and neurotransmitter peptides.

A literature review by an international group of physicians shows that the physiological skin parameters differ among men and women suggesting that treatment choices should differ as well.

EADV report summarizes the latest advances in laser technology for tattoo removal.

Dermatologists should consider using the diuretic drug spironolactone to treat acne in women instead of antibiotics, researchers report. 

Study of 144 female students shows that stress may increase acne severity.

In this month's Cosmetic Conundrums column, Dr. Draelos addresses “tight skin,” the use of menthol in skin care products and over-the-counter itch relieving products.

The new Thermage FLX adds speed and ease of use to the only monopolar radiofrequency (RF) device FDA-cleared for use on body and facial locations, including the eyelids, with a single treatment.

The September 2018 issue of Dermatology Times includes a special supplment on treating acne scarring. It highlights some of the latest advances in treating patients who suffer from this condition.

While claims don’t always lead to court cases, they can lead to stress, says Stephen E. Wolverton, M.D., a dermatologist with Indiana University Health in Bloomington, Ind. Learn more about managing the stress associated with malpractice claims.

False eyelashes and hair extensions could become a problem if it becomes representative of the “ideal” woman.

It can be difficult to find the time to have well-rounded interests. Podcasts can help keep you up-to-speed on everything from hobbies and personal interests to current events. Listen in bed, in the car, or on the treadmill-this medium offers flexibility and pleasure. Check out some of our recommendations on podcasts to tune in to.

This month we feature new products from MiraDry, Qosmedix, Rekze and Syneron Candela for conditions ranging from underarm sweating to rosacea and cellulite.

In this month's Cosmetic Conundrums column, Dr. Draelos addresses why fatty acids are essential in skin health, how best to treat estrogen deficient skin and she asks, "What is the skin natural moisturizing factor?"

Researchers writing in the Journal of Clinical and Aesthetic Dermatology outline 10 treatments for acne scarring, plus possible future treatments.

The Food and Drug Administration is in the process of evaluating scientific data on the safety of probiotics and postbiotics in cosmetics, said Linda Katz, M.D., director of the Office of Cosmetics and Color for the FDA.

Here's a look at new botulinum toxin treatments on the horizon.

In June, Dermira Inc. announced the FDA approval of Qbrexza (glycopyrronium) for primary axillary hyperhidrosis ― excessive underarm sweating.